Press Releases NanoString Technologies, Inc.

Equities

NSTGQ

US63009R1095

Delayed OTC Markets Other stock markets 03:52:09 2024-05-01 pm EDT			5-day change	1st Jan Change
0.179 ^USD	-30.36%		-40.33%	-76.08%

Apr. 22	Bruker Agrees Signs Asset Purchase Deal With NanoString Technologies	MT
Apr. 19	Motion for Asset Sale Approved for NanoString Technologies, Inc.	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

The UPC Court Of Appeal's First Decision: What Does It Mean For The Assessment Of Inventive Step At The UPC?	Apr. 16	AQ
NanoString Products Drive Breakthrough Cancer Research at the 2024 American Association of Cancer Research Conference	Apr. 05	AQ
UPC CoA: No Stay Of UPC Court Proceedings During Chapter 11 Proceedings	Mar. 15	AQ
NanoString Announces Completion of Financing to Support Restructuring Process	Feb. 12	AQ
NanoString Announces Completion of Financing to Support Restructuring Process	Feb. 09	BU
NanoString Takes Steps to Restructure Its Business and Protect Its Mission to Map the Universe of Biology	Feb. 04	BU
NanoString Launches the CosMx 6,000 plex RNA Assay and Showcases Whole Transcriptome Imaging Capability	Feb. 01	BU
NanoString’s CosMx SMI Achieves Whole Transcriptome Imaging at Single-Cell Resolution	Jan. 07	BU
NanoString Reports Inducement Grants Under Nasdaq Listing Rules	Jan. 05	BU
NanoString to Webcast Presentation from 42nd Annual J.P. Morgan Healthcare Conference	Jan. 04	BU
The UPC's Approach To Validity – What Can We Learn From The Reasoned Decision In The 10X Genomics v NanoString Technologies First PI Application?	Dec. 13	AQ
NanoString Comments on Delaware District Court Verdict	Nov. 19	BU
NanoString Technologies to Present Portfolio of Cutting-edge Brain Research and Novel Spatial Biology Applications for Neuroscience	Nov. 09	BU
NanoString to Webcast Presentations from Upcoming Healthcare Conferences	Nov. 09	BU
NanoString: Q3 Earnings Snapshot	Nov. 06	AQ
NanoString Technologies Releases Operating Results for Third Quarter of 2023	Nov. 06	BU
NanoString Customers Present First Data Using the Most Comprehensive Spatial Proteomics Panel Available	Nov. 01	BU
10x Genomics Comments on Second UPC Preliminary Injunction Decision	23-10-10	PR
NanoString Provides Preliminary Financial and Operational Highlights for Third Quarter of 2023	23-10-10	BU
A STAR's Genome Institute of Singapore, NanoString and Next Level Genomics Establish Joint Lab to Advance Studies of Complex Diseases with Spatial Genomics	23-10-04	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases NanoString Technologies, Inc.

Equities

NSTGQ

US63009R1095

Press Releases

Filters